Literature DB >> 7042109

Improvement of glucose tolerance and lowering of glycohemoglobin and serum lipid concentrations after discontinuation of antihypertensive drug therapy.

R P Ames, P Hill.   

Abstract

Diuretic-based antihypertensive drug therapy causes a disturbance in glucose tolerance and in serum lipid and lipoprotein concentrations. To determine the reversibility of the glucose intolerance and to identify mechanisms of the metabolic alterations, we examined a short glucose tolerance test and insulin, glycohemoglobin and lipid concentrations during the supervised withdrawal of long-term drug therapy in 35 patients with primary hypertension. An average of 7 weeks after stopping drugs, glucose tolerance and glycohemoglobin improved, total cholesterol decreased 18 mg/dl, triglyceride decreased 27 mg/dl, and the ratio of total to high-density lipoprotein cholesterol decreased (p less than 0.01 for all variables vs treatment values). The changes in lipid concentrations from the treated to untreated state correlated with the changes in glycohemoglobin and indexes of glucose metabolism. The findings suggest that insulin resistance develops during drug therapy and disturbs both glucose and lipid metabolism. Attention to these alterations may provide directions for further control of atherosclerotic complications during the treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042109     DOI: 10.1161/01.cir.65.5.899

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

Review 1.  Metabolic issues in the Antihypertensive and Lipid-Lowering Heart Attack Trial Study.

Authors:  Henry A Punzi; Connie F Punzi
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

2.  Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension.

Authors:  G E McVeigh; E B Dulie; A Ravenscroft; D B Galloway; G D Johnston
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

Review 3.  Insulin resistance and hypertension--implications for treatment.

Authors:  P A Rutherford; T H Thomas; R Wilkinson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

4.  Hyperglycemic effects of hydrochlorothiazide and propranolol. A biochemical and ultrastructural study.

Authors:  G Papaccio; V Esposito
Journal:  Acta Diabetol Lat       Date:  1987 Oct-Dec

5.  Multiple risk factor intervention trial.

Authors:  M A Mishkel
Journal:  Can Med Assoc J       Date:  1983-05-15       Impact factor: 8.262

6.  Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial.

Authors:  T M Erwteman; N Nagelkerke; J Lubsen; M Koster; A J Dunning
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

7.  Metabolic parameters after changing from hydrochlorothiazide to verapamil treatment in hypertension.

Authors:  A Lehtonen; A Gordin
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 8.  The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

9.  The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.

Authors:  C Lucas; P Jenkins; J Mendels; D Due; W P Forbes; M A Sirgo
Journal:  J Natl Med Assoc       Date:  1991-10       Impact factor: 1.798

10.  Effects of a new diuretic piretanide on glucose tolerance, insulin secretion and 125I-insulin binding.

Authors:  K Harno; M Välimäki; M Verho
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.